Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shixia Gong
Institution:
Nanjing University of Chinese Medicine
Observed institution:
Nanjing University of Chinese Medicine
ORCID:
0009-0000-5841-6939
Observed ORCID:
0009-0000-5841-6939
OpenAlex ID:
A5069856097
Individualized therapy based on the combination of mini‑PDX and NGS for a patient with metastatic AFP‑producing and HER‑2 amplified gastric cancer
2022
·
Xiaodan Zhu
, Xiaoqing Xu
, et al.
·
Oncology Letters
·
10
PDF
Research Advances of Extrachromosomal Circular DNA in Breast Cancer
2025
·
Xiaodan Zhu
, Yiyang Qian
, et al.
·
Cancer Medicine
·
6
PDF
[Corrigendum] Individualized therapy based on the combination of mini‑PDX and NGS for a patient with metastatic AFP‑producing and HER‑2 amplified gastric cancer
2026
·
Xiaodan Zhu
, Xiaoqing Xu
, et al.
·
Oncology Letters
PDF
Abstract B057: Clinical utility and in vitro anti-proliferative activity of a tissue-agnostic multi-target formula (WD-3) in rare malignancies
2026
·
Xiaodan Zhu
, Quan Tang
, et al.
·
Cancer Research
LncRNA LINC01579/miR-579-3p axis promotes gastric cancer progression via NOTCH1 pathway
2026
·
Yuqing Geng
, Shixia Gong
, et al.
·
World Journal of Surgical Oncology
Efficacy and Safety of Acupoint Application with Weitiao Formula for Delayed Chemotherapy-Induced Nausea and Vomiting: A Pilot Randomized, Double-Blind, Placebo-Controlled Trial
2026
·
Xiaodan Zhu
, Shixia Gong
, et al.
·
SSRN Electronic Journal
Show more works
View as search
Works count:
6
Citation count:
16
H-index:
2
I10-index:
1
Year
Topic
Type